ARMATA PHARMACEUTICALS, INC. Public Float
ARMATA PHARMACEUTICALS, INC. (ARMP) had Public Float of $21.10 million as of 2025-06-30, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-25
- 2025-06-30: Entity Public Float $21.10M.
- 2024-06-28: Entity Public Float $30.30M.
- 2023-06-30: Entity Public Float $12.50M.
- 2022-06-30: Entity Public Float $41.90M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $21.10M 10-K · filed 2026-03-25 |
| 2024-06-28 | $30.30M 10-K · filed 2025-03-21 |
| 2023-06-30 | $12.50M 10-K · filed 2024-03-21 |
| 2022-06-30 | $41.90M 10-K · filed 2023-03-16 |
| 2021-06-30 | $38.90M 10-K · filed 2022-03-17 |
| 2020-06-30 | $37.70M 10-K · filed 2021-03-18 |
| 2019-06-28 | $38.90M 10-K · filed 2020-03-19 |
| 2018-06-29 | $18.60M 10-K · filed 2019-03-25 |
| 2017-06-30 | $6.57M 10-K · filed 2018-03-14 |
| 2016-06-30 | $16.27M 10-K · filed 2017-03-27 |
| 2015-06-30 | $37.55M 10-K · filed 2016-03-30 |
| 2014-06-30 | $62.22M 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |